According to a new market report published by Lucintel, the future of the functional genomic market looks promising with opportunities in the clinical and research laboratories, academic and government institutes, hospitals and clinics, pharmaceutical and biotechnology industry. The global functional genomic market is expected to grow with a CAGR of XX% from 2020 to 2025. The major drivers for this market are constantly reducing prices of genetic procedures and rising usage of genomics in R&D of new drugs.
Functional genomic is a field of molecular biology that describe functions and interactions of gene (and protein). Functional genomics use vast data which are generated by genomic and transcriptomic projects. In this market, PCR (Polymerase Chain Reaction), sequencing, microarray, nucleic acid extraction and purification are the major technologies. Lucintel forecasts that PCR will remain the largest segment over the forecast period due to rising research activities and low cost of DNA (Deoxyribonucleic Acid) amplification using PCR.
Within this market, pharmaceutical and biotechnology companies will remain the largest segment by end user over the forecast period due to rising genetic research studies for development of drugs with fewer side effects and improving drug discovery process.
North America will remain the largest region over the forecast period due to rising investment in research by government organizations and presence of advanced healthcare infrastructure in the region.
Thermo Fisher Scientific, Agilent Technologies, Eppendorf, and Bio-Rad Laboratories are among the major suppliers in the global functional genomic market.
Lucintel, a leading global strategic consulting and market research firm, has analyzed growth opportunities in the global functional genomic market by deliverable, technology, end user, and region. Lucintel has prepared a comprehensive research report titled “Growth Opportunities in the Global Functional Genomic Market 2020-2025: Trends, Forecast, and Opportunity Analysis.” This Lucintel report serves as a catalyst for growth strategy, as it provides comprehensive data and analysis on trends, key drivers, and directions. The study includes trends and forecast for the global functional genomic market by deliverable, technology, end user, and region as follows:
By Deliverable [Value ($ Million) shipment analysis for 2014 – 2025]:
Products
Instruments and Softwares
Consumables and Reagents
Services
Core Genomics Services
NGS-based Services
Biomarker Translation Services
Computational Services
Others
By Technology [Value ($ Million) shipment analysis for 2014 – 2025]:
Polymerase Chain Reaction (PCR)
Sequencing
Microarray
Nucleic Acid Extraction and Purification
Other Technologies
By End User [Value ($ Million) shipment analysis for 2014 – 2025]:
Clinical and Research Laboratories
Academic and Government Institutes
Hospitals and Clinics
Pharmaceutical and Biotechnology Companies
Other End Users
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
United States
Canada
Mexico
United Kingdom
Germany
France
A more than 150 pages research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or visit us at helpdesk@lucintel.com.
About Lucintel
Lucintel, the premier global Management Consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, Growth Consulting, M&A, and Due diligence services to executives and key decision makers in a variety of industries. For further information, visit www.lucintel.com.